Oral Lesions from Nevirapine-Related Stevens Johnson Syndrome
Author Information
Author(s): Balasundaram S, Ranganathan K, Umadevi K, Gunaseelan R, Kumaraswamy N, Solomon Sunithi, Devaleenol Bella, Ambrose Pradeep
Primary Institution: Chennai Dental Research Foundation, Chennai, Tamil Nadu, India
Hypothesis
Can nevirapine therapy in HIV patients lead to Stevens Johnson syndrome and associated oral lesions?
Conclusion
The study reports four cases of Stevens Johnson syndrome in HIV patients following nevirapine therapy, highlighting the need for careful monitoring.
Supporting Evidence
- All four patients developed severe oral lesions after starting nevirapine therapy.
- Three patients experienced elevated liver enzymes and hepatitis.
- Two patients had ocular involvement as part of their symptoms.
Takeaway
Some medicines for HIV can cause serious skin problems, and this study looked at four people who had bad reactions after taking one of those medicines.
Methodology
Case reports of four HIV seropositive patients experiencing Stevens Johnson syndrome after starting nevirapine therapy.
Limitations
The study is based on a small number of cases, limiting generalizability.
Participant Demographics
Four HIV seropositive patients, including a child and adults aged 39 to 50.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website